Main
>
RHEUMATOLOGY>RHEUMATOID ARTHRITIS
>
Treatment
>
OfatumuMAb (Phase III)
>
Co.: UK. G. (Anti CD20 MAb/Patents)
>
Licensor
This data is not available for free
Licensor's products
This section has no products